Valeo Financial Advisors, LLC Novo Cure LTD Transaction History

Valeo Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$130.4 - $225.58 $7,824 - $13,534	-60 Closed	0 $0
Q1 2021 Apr 12, 2021	SELL	$124.11 - $190.17 $5,584 - $8,557	-45 Reduced 42.86%	60 $8,000
Q4 2020 Feb 11, 2021	BUY	$112.16 - $174.14 $11,776 - $18,284	105 New	105 $18,000
Q3 2020 Oct 28, 2020	SELL	$58.05 - $111.31 $8,243 - $15,806	-142 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$57.2 - $74.41 $171 - $223	3 Added 2.16%	142 $8,000
Q4 2019 Jan 24, 2020	BUY	$68.3 - $93.8 $9,493 - $13,038	139 New	139 $12,000
Q4 2018 Jan 30, 2019	SELL	$28.72 - $52.63 $1,809 - $3,315	-63 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$32.0 - $52.4 $2,016 - $3,301	63 New	63 $2,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.